A Phase I, pharmacokinetic and biologic correlative study of oblimersen sodium (GenasenseTM, G3139) and irinotecan in patients with metastatic colorectal cancer

M. M. Mita, L. Ochoa, E. K. Rowinsky, J. Kuhn, G. Schwartz, L. A. Hammond, A. Patnaik, I. T. Yeh, E. Izbicka, K. Berg, A. W. Tolcher, Tobias Arkenau, David Cunningham

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Pages (from-to)20-21
Number of pages2
JournalAdvances in Gastrointestinal Cancers
Volume4
Issue number1
StatePublished - Mar 2006
Externally publishedYes

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology
  • Cancer Research

Cite this